Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Albenatide in Type 2 Diabetes on Metformin
NCT00638716Phase 2Completed
- Sponsor
- ConjuChem
- Start
- Feb 2008
- Primary completion
- Nov 2008
- Modality
- Modified Peptides, Native Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of albenatide in type 2 diabetes mellitus (T2DM), sponsored by ConjuChem. Started Feb 2008; status: completed.
02
Drugs
albenatide
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00638716.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00638716.